KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

Blood · 2025-Jun-12 · PMID 40090011

Panel B质量警告待 EXE 对齐验证

Time to first use of rescue therapy

Figure 3. Time to event analyses. Kaplan-Meier plot of time to first platelet count of ≥50 × 10 9 /L or ≥30 × 10 9 /L and doubled from baseline (A) and time to first use of rescue therapy (B) during the 24-week double-blind period. Cox regression model was used with treatment group and stratification factors as covariates. Log-rank test was adjusted by stratification factors.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过否
预期曲线2
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T18:08:23+00:00